Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Return on Capital %

Albireo Pharma Inc Return on Capital % Chart (ALBO)

Albireo Pharma Inc annual/quarterly Return on Capital % from 2016 to 2020.
  • Albireo Pharma Inc Return on Capital % for the quarter ending June 06, 2020 was -41.11 a -11.79% increase of 4.85 year over year
  • Albireo Pharma Inc Return on Capital % for the last 12 months ending June 06, 2020 was -44.23 a 23.86% decrease of -10.55 year over year
  • Albireo Pharma Inc Annual Return on Capital % for 2019 was -34.64 a 27.20% decrease of -9.42 from 2018
  • Albireo Pharma Inc Annual Return on Capital % for 2018 was -25.22 a -32.20% increase of 8.12 from 2017
  • Albireo Pharma Inc Annual Return on Capital % for 2017 was -33.34 a 36.14% decrease of -12.05 from 2016
Other Margins & Efficiency Metrics:
  • Albireo Pharma Inc EBITDA Margin for the quarter ending March 03, 2018 was $-5m
  • Albireo Pharma Inc Return on Equity % for the quarter ending September 09, 2018 was -39.21 a 23.24% decrease of -9.11 year over year
View Chart On Koyfin

Quarterly ALBO Return on Capital % Data

06/2020-41.11
03/2020-68.32
12/2019-24.09
09/2019-45.96
06/2019-33.24
03/2019-32.74
12/2018-27.48
09/2018-22.13
06/2018-16.80
03/2018-1.29

Annual ALBO Return on Capital % Data

2019-34.64
2018-25.22
2017-33.34
2016-21.29
2015-152.18